Clinical Cases
Acquired Inhibitors of Coagulation in a Patient With Systemic Lupus Erythematosus and Antiphospholipid Antibodies: Response to Rituximab
Inhibidores adquiridos de la coagulación en una paciente con lupus eritematoso sistémico y anticuerpos antifosfolipídicos: respuesta a rituximab
Read
4799
Timeswas read the article
2664
Total PDF
2135
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 3 | 5 |
| 2025 5 | 73 | 74 | 147 |
| 2025 4 | 53 | 32 | 85 |
| 2025 3 | 50 | 33 | 83 |
| 2025 2 | 55 | 34 | 89 |
| 2025 1 | 49 | 58 | 107 |
| 2024 12 | 19 | 60 | 79 |
| 2024 11 | 31 | 77 | 108 |
| 2024 10 | 20 | 36 | 56 |
| 2024 9 | 16 | 20 | 36 |
| 2024 8 | 32 | 43 | 75 |
| 2024 7 | 26 | 51 | 77 |
| 2024 6 | 31 | 41 | 72 |
| 2024 5 | 28 | 43 | 71 |
| 2024 4 | 30 | 28 | 58 |
| 2024 3 | 31 | 43 | 74 |
| 2024 2 | 19 | 26 | 45 |
| 2024 1 | 18 | 20 | 38 |
| 2023 12 | 36 | 40 | 76 |
| 2023 11 | 15 | 31 | 46 |
| 2023 10 | 25 | 39 | 64 |
| 2023 9 | 26 | 43 | 69 |
| 2023 8 | 17 | 17 | 34 |
| 2023 7 | 21 | 28 | 49 |
| 2023 6 | 14 | 27 | 41 |
| 2023 5 | 14 | 12 | 26 |
| 2023 4 | 11 | 8 | 19 |
| 2023 3 | 16 | 31 | 47 |
| 2023 2 | 20 | 26 | 46 |
| 2023 1 | 16 | 9 | 25 |
| 2022 12 | 39 | 44 | 83 |
| 2022 11 | 38 | 26 | 64 |
| 2022 10 | 24 | 32 | 56 |
| 2022 9 | 18 | 35 | 53 |
| 2022 8 | 29 | 39 | 68 |
| 2022 7 | 18 | 40 | 58 |
| 2022 6 | 19 | 30 | 49 |
| 2022 5 | 22 | 38 | 60 |
| 2022 4 | 33 | 45 | 78 |
| 2022 3 | 32 | 46 | 78 |
| 2022 2 | 16 | 35 | 51 |
| 2022 1 | 20 | 52 | 72 |
| 2021 12 | 30 | 45 | 75 |
| 2021 11 | 19 | 46 | 65 |
| 2021 10 | 25 | 55 | 80 |
| 2021 9 | 24 | 46 | 70 |
| 2021 8 | 19 | 62 | 81 |
| 2021 7 | 22 | 44 | 66 |
| 2021 6 | 26 | 44 | 70 |
| 2021 5 | 32 | 39 | 71 |
| 2021 4 | 54 | 93 | 147 |
| 2021 3 | 42 | 43 | 85 |
| 2021 2 | 31 | 26 | 57 |
| 2021 1 | 18 | 25 | 43 |
| 2020 12 | 23 | 30 | 53 |
| 2020 11 | 26 | 25 | 51 |
| 2020 10 | 14 | 21 | 35 |
| 2020 9 | 29 | 25 | 54 |
| 2020 8 | 19 | 30 | 49 |
| 2020 7 | 14 | 18 | 32 |
| 2020 6 | 32 | 28 | 60 |
| 2020 5 | 24 | 23 | 47 |
| 2020 4 | 17 | 19 | 36 |
| 2020 3 | 25 | 7 | 32 |
| 2020 2 | 4 | 0 | 4 |
| 2020 1 | 10 | 0 | 10 |
| 2019 12 | 4 | 0 | 4 |
| 2019 11 | 1 | 0 | 1 |
| 2019 9 | 7 | 0 | 7 |
| 2019 7 | 1 | 0 | 1 |
| 2019 6 | 3 | 0 | 3 |
| 2019 4 | 1 | 0 | 1 |
| 2019 3 | 2 | 0 | 2 |
| 2019 2 | 1 | 0 | 1 |
| 2019 1 | 2 | 0 | 2 |
| 2018 5 | 3 | 1 | 4 |
| 2018 4 | 26 | 18 | 44 |
| 2018 3 | 12 | 21 | 33 |
| 2018 2 | 7 | 5 | 12 |
| 2018 1 | 8 | 6 | 14 |
| 2017 12 | 10 | 14 | 24 |
| 2017 11 | 15 | 19 | 34 |
| 2017 10 | 12 | 10 | 22 |
| 2017 9 | 11 | 18 | 29 |
| 2017 8 | 10 | 10 | 20 |
| 2017 7 | 10 | 28 | 38 |
| 2017 6 | 29 | 18 | 47 |
| 2017 5 | 27 | 21 | 48 |
| 2017 4 | 16 | 23 | 39 |
| 2017 3 | 23 | 39 | 62 |
| 2017 2 | 7 | 20 | 27 |
| 2017 1 | 13 | 16 | 29 |
| 2016 12 | 32 | 22 | 54 |
| 2016 11 | 25 | 14 | 39 |
| 2016 10 | 40 | 17 | 57 |
| 2016 9 | 43 | 18 | 61 |
| 2016 8 | 22 | 9 | 31 |
| 2016 7 | 11 | 8 | 19 |
Show all
